Literature DB >> 118526

Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man.

A Heimdahl, C E Nord.   

Abstract

Phenoxymethylpenicillin in capsules was given orally in doses of 800 mg twice daily for 7 days to 10 subjects. Saliva, throat and faecal specimens were taken up to 29 days for cultivation of aerobic and anaerobic bacteria. No changes in the normal flora in saliva, throat or faeces were noticed during the observation period. Clindamycin was given orally in doses of 150 mg 4 times daily to 10 other subjects. No changes in the aerobic oral flora were observed, while a significant decrease in the number of anaerobic bacteria occurred. In 2 volunteers, overgrowth of clindamycin-resistant clostridia were seen from days 4--16 in one and from days 2--7 in the other. The throat flora showed changes similar to the oral flora. Pronounced changes in the aerobic and anaerobic faecal bacterial flora occurred. Thus among the aerobes enterococci proliferated and among the anaerobes significant decreases in the number of cocci and gram-negative rods were noticed. In 4 subjects, clindamycin-resistant clostridia increased 4log. One of them developed diarrhoea and harboured an unidentified toxin-producing clostridial strain rather similar to Clostridium difficile.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 118526     DOI: 10.3109/inf.1979.11.issue-3.11

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  38 in total

1.  Microflora changes with norfloxacin and pivmecillinam in women with recurrent urinary tract infection.

Authors:  Birgit Stattin Norinder; Ragnar Norrby; Ann-Chatrin Palmgren; Sofia Hollenberg; Ulla Eriksson; Carl Erik Nord
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

2.  Effect of meropenem on the intestinal microflora.

Authors:  T Bergan; C E Nord; S B Thorsteinsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

3.  Effect of lomefloxacin on the normal oral and intestinal microflora.

Authors:  C Edlund; B Brismar; C E Nord
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

4.  Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers.

Authors:  H Lode; C Müller; K Borner; C E Nord; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Comparative effects of cefadroxil and phenoxymethylpenicillin on the normal oropharyngeal and intestinal microflora.

Authors:  I Adamsson; C Edlund; S Sjöstedt; C E Nord
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

6.  Clostridium difficile-associated diarrhoea in uremic patients.

Authors:  B Aronsson; P Barany; C E Nord; B Nyström; P Stenvinkel
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

7.  Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.

Authors:  M Ritz; H Lode; M Fassbender; K Borner; P Koeppe; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

8.  Gastrin, gastric acid secretion, and gastric microflora in patients with rheumatoid arthritis.

Authors:  K Henriksson; K Uvnäs-Moberg; C E Nord; C Johansson; R Gullberg
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103

9.  Antimicrobial resistance in human oral and intestinal anaerobic microfloras.

Authors:  C A Stark; C Edlund; S Sjöstedt; G Kristensen; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

10.  The effect of piperacillin prophylaxis on the colonic microflora In patients undergoing colorectal surgery.

Authors:  L Kager; A S Malmborg; C E Nord; S Sjöstedt
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.